The Trump administration is considering encouraging lowering drug costs through outcome-based contracts, but there is little evidence the approach works.
Published: July 10, 2017 at 02:00AM
from NYT Health https://ift.tt/2u07daw
The Trump administration is considering encouraging lowering drug costs through outcome-based contracts, but there is little evidence the approach works.
Published: July 10, 2017 at 02:00AM
from NYT Health https://ift.tt/2u07daw